BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 23745650)

  • 1. A ten-year clinical update of a large RET p.Gly533Cys kindred with medullary thyroid carcinoma emphasizes the need for an individualized assessment of affected relatives.
    Signorini PS; França MI; Camacho CP; Lindsey SC; Valente FO; Kasamatsu TS; Machado AL; Salim CP; Delcelo R; Hoff AO; Cerutti JM; Dias-da-Silva MR; Maciel RM
    Clin Endocrinol (Oxf); 2014 Feb; 80(2):235-45. PubMed ID: 23745650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple endocrine neoplasia 2A due to a unique C609S RET mutation presents with pheochromocytoma and reduced penetrance of medullary thyroid carcinoma.
    Kinlaw WB; Scott SM; Maue RA; Memoli VA; Harris RD; Daniels GH; Porter DM; Belloni DR; Spooner ET; Ernesti MM; Noll WW
    Clin Endocrinol (Oxf); 2005 Dec; 63(6):676-82. PubMed ID: 16343103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. When is prophylactic thyroidectomy indicated for patients with the RET codon 609 mutation?
    Calva D; O'Dorisio TM; Sue O'Dorisio M; Lal G; Sugg S; Weigel RJ; Howe JR
    Ann Surg Oncol; 2009 Aug; 16(8):2237-44. PubMed ID: 19472011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical diagnosis and treatment of familial medullary thyroid carcinoma caused by a p.C618Y RET proto-oncogene mutation in a Chinese pedigree].
    Zhao JQ; Guo L; Qi XP; Chen ZG; Wang KJ; Lou JL; Yu XH; Cheng J; Jin HY; Li XL; Ying RB; Zhang XN
    Zhonghua Yi Xue Za Zhi; 2013 Feb; 93(6):440-4. PubMed ID: 23660264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experience of prophylactic thyroidectomy in multiple endocrine neoplasia type 2A kindreds with RET codon 804 mutations.
    Learoyd DL; Gosnell J; Elston MS; Saurine TJ; Richardson AL; Delbridge LW; Aglen JV; Robinson BG
    Clin Endocrinol (Oxf); 2005 Dec; 63(6):636-41. PubMed ID: 16343097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prophylactic thyroidectomy in children who are carriers of a multiple endocrine neoplasia type 2 mutation: description of 20 cases and recommendations based on the literature].
    de Groot JW; Links TP; Rouwe CW; van der Wal JE; Hofstra RM; Plukker JT
    Ned Tijdschr Geneeskd; 2006 Feb; 150(6):311-8. PubMed ID: 16503023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New mutations in the RET protooncogene-L881V - associated with medullary thyroid carcinoma and -R770Q - in a patient with mixed medullar/follicular thyroid tumour.
    Frank-Raue K; Döhring J; Scheumann G; Rondot S; Lorenz A; Schulze E; Dralle H; Raue F; Leidig-Bruckner G
    Exp Clin Endocrinol Diabetes; 2010 Aug; 118(8):550-3. PubMed ID: 20013610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and oncological features of children and young adults with multiple endocrine neoplasia type 2A.
    Puñales MK; da Rocha AP; Meotti C; Gross JL; Maia AL
    Thyroid; 2008 Dec; 18(12):1261-8. PubMed ID: 18991485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medullary thyroid carcinoma.
    Pacini F; Castagna MG; Cipri C; Schlumberger M
    Clin Oncol (R Coll Radiol); 2010 Aug; 22(6):475-85. PubMed ID: 20627492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New era: prophylactic surgery for patients with multiple endocrine neoplasia-2a.
    Gosnell JE; Sywak MS; Sidhu SB; Gough IR; Learoyd DL; Robinson BG; Delbridge LW
    ANZ J Surg; 2006 Jul; 76(7):586-90. PubMed ID: 16813623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RET proto-oncogene testing in infants presenting with Hirschsprung disease identifies 2 new multiple endocrine neoplasia 2A kindreds.
    Fialkowski EA; DeBenedetti MK; Moley JF; Bachrach B
    J Pediatr Surg; 2008 Jan; 43(1):188-90. PubMed ID: 18206480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patients with RET D631Y mutations most commonly present with pheochromocytoma and not medullary thyroid carcinoma.
    Elston MS; Meyer-Rochow GY; Holdaway I; Conaglen JV
    Horm Metab Res; 2012 May; 44(5):339-42. PubMed ID: 22274720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The clinical patterns and RET proto-oncogene in fifteen multiple endocrine neoplasia type 2A pedigrees].
    Zhou YL; Zhu SX; Li JJ; Liu JB; Yin M; Xiao BY; Yu CL; Wang LM; Gu LQ; Cui B; Ning G; Li XY; Zhao YJ
    Zhonghua Nei Ke Za Zhi; 2007 Jun; 46(6):466-70. PubMed ID: 17663821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hirschsprung's disease, RET proto-oncogene mutation and prophylactic thyroidectomy].
    Marcacuzco Quinto AA; Martínez Pueyo JI; Gómez Rodríguez P; de la Cruz Vigo F
    Med Clin (Barc); 2014 Aug; 143(4):185-6. PubMed ID: 24342010
    [No Abstract]   [Full Text] [Related]  

  • 15. Prophylactic thyroidectomy in multiple endocrine neoplasia type 2A.
    Skinner MA; Moley JA; Dilley WG; Owzar K; Debenedetti MK; Wells SA
    N Engl J Med; 2005 Sep; 353(11):1105-13. PubMed ID: 16162881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Familial medullary carcinoma prevention, risk evaluation, and RET in children of families with MEN2.
    Moore SW; Appfelstaedt J; Zaahl MG
    J Pediatr Surg; 2007 Feb; 42(2):326-32. PubMed ID: 17270543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The clinical spectrum of RET proto-oncogene mutations in codon 790.
    Bihan H; Murat A; Fysekidis M; Al-Salameh A; Schwartz C; Baudin E; Thieblot P; Borson-Chazot F; Guillausseau PJ; Cardot-Bauters C; Raingeard I; Requeda E; Sadoul JL; Reznik Y;
    Eur J Endocrinol; 2013 Sep; 169(3):271-6. PubMed ID: 23756355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prophylactic thyroidectomy in children and young people with hereditary medullary thyroid carcinoma: a Chilean experience].
    Ramos C; Ojeda D; Cohn D; Wohllk N
    Rev Med Chil; 2005 Sep; 133(9):1029-36. PubMed ID: 16311694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age-related neoplastic risk profiles and penetrance estimations in multiple endocrine neoplasia type 2A caused by germ line RET Cys634Trp (TGC>TGG) mutation.
    Milos IN; Frank-Raue K; Wohllk N; Maia AL; Pusiol E; Patocs A; Robledo M; Biarnes J; Barontini M; Links TP; de Groot JW; Dvorakova S; Peczkowska M; Rybicki LA; Sullivan M; Raue F; Zosin I; Eng C; Neumann HP
    Endocr Relat Cancer; 2008 Dec; 15(4):1035-41. PubMed ID: 18794325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical spectrum of MEN2A in a large family caused by the infrequent RET mutation Cys609Phe.
    Oriola J; Biarnes J; Hernandez C; Simó R
    Clin Genet; 2013 Apr; 83(4):384-7. PubMed ID: 22734615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.